The Valley Desk

NCT05952557 · Interventional trial

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Overall registry status Active not recruiting

Phase 3

Conditions Breast Cancer, Early Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov